MedPath

Effect of Dexmedetomidine on the Quality of Recovery in Parturients Undergoing Elective Caesarean Sections

Phase 4
Completed
Conditions
The Quality of Recovery (ObsQOR-11)
Interventions
Registration Number
NCT05991466
Lead Sponsor
Cairo University
Brief Summary

The study hypothesizes that addition of dexmedetomidine to bupivacaine either in spinal anesthesia or TAP block is more effective and provide better ObsQor-11score than bupivacaine alone. Also, Dexmedetomidine in TAP block might provide a longer pain free time in comparison to intrathecal dexmedetomidine.

Detailed Description

Aim of the work To compare the quality of recovery (ObsQOR-11) in patients undergoing cesarean sections receiving dexmedetomedine either intrathecally or in the tap block in comparison to patients receiving conventional spinal anesthesia and tap block.

Statistical Analysis I. Sample size In a pilot study on 5 parturient who had undergone elective cesarean section under spinal anesthesia followed by TAP block with bupivacaine alone, the mean ObsQoR-11 at 24 hours was 65±9. In a single factor ANOVA study, sample size of 126 from the 3 groups is needed to detect a difference of at least 10 using the Tukey-Kramer (Pairwise) multiple comparison with study power of 83% and alpha error of 0.05. The common standard deviation within a group is assumed to be 9. The number of envelopes will be increased to 141 (47 per group) to compensate of possible 10% dropout. The sample size was calculated using PASS 15 Power Analysis and Sample Size Software (2017). NCSS, LLC. Kaysville, Utah, USA, ncss.com/software/pass.

II. Statistical analysis Data will be coded and entered using the statistical package SPSS (statistical package for the social science) version 22. Data will be summarized using mean, standard deviation, median, minimum and maximum in quantitative data and using frequency (count) and relative frequency(percentage)for categorical data. Comparisons between quantitative variables will be done using the non parametric Mann-Whitney test. For comparing categorical data, Chi square (x2 ) test will be performed. Exact test will be used instead when the expected frequency is less than 5. P-value less than 0.05 will be considered as statistically significant.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
141
Inclusion Criteria
  • Participants will be full-term pregnant females
  • ASA classification I or ll.
  • Aged between 18 and 40 years.
  • Singleton pregnancy
Exclusion Criteria
  • Refusal of block.
  • Bleeding disorders (platelets count <150,000; INR>1.5; PC<60%).
  • wounds or infection at the puncture site.
  • Known allergy to local anesthetic drugs.
  • Contraindications to neuroaxial block.
  • Contraindications to TAP block..

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group(A)DexmedetomidineSpinal anaesthesia will be performed with 0.5% hyperbaric bupivacaine 10-12 mg and TAP block will be performed with 30 ml 0.25% bupivacaine in each side.
Group (B)DexmedetomidineSpinal anaesthesia will be performed with 0.5% hyperbaric bupivacaine10-12 mg and TAP block will be performed with 50 mcg Dexmedetomidine added to 30ml 0.25% bupivacaine in each side.
Group (C)DexmedetomidineSpinal anaesthesia will be performed with 0.5% hyperbaric bupivacaine 10-12 mg added to 5 mcg dexmedetomidine. TAP block will be performed with 30ml 0.25% bupivacaine in each side.
Primary Outcome Measures
NameTimeMethod
Quality of recovery score following CS (ObsQor-11) at the end of the first 24 hours postoperative.24 hours postoperative

The mothers will be asked to rate each recovery item with an 11-point numerical Likert scale (0 = strongly negative; 10 = strongly positive).

Secondary Outcome Measures
NameTimeMethod
Incidence of bradycardiapost spinal anesthesia up to 1 hour

heart rate less than 60 beats per minute

Time of first request of analgesia in hourswithin 24 hours postoperative

from time of spinal anesthesia to the first registration of VAS score more than 3

Onset of sensory blockPost spinal anesthesia up to 30 minutes

defined as the time needed to lose cold sensation when using the ice-cold test at the T6 dermatome level) and time to 2-segment regression of spinal anesthesia.

Neonatal Apgar scoreat 1 and 5 minutes post delivery

This scoring system provided a standardized assessment for infants after delivery. The Apgar score comprises five components: 1) color, 2) heart rate, 3) reflexes, 4) muscle tone, and 5) respiration, each of which is given a score of 0, 1, or 2.

Incidence of hypotensionpost spinal anesthesia up to 1 hour

systolic blood pressure \< 90 or \<70% of baseline

Intra operative non-invasive mean blood pressurewithin 24 hours postoperative

in mmhg

Complications of spinal anaesthesia and TAP block12 hours post operative period.

Complications of spinal anaesthesia and TAP block

Ramsay sedation scale1, 2, 4, 6, 8, 12 and 24 hours

1. Awake; agitated or restless or both

2. Awake; cooperative, oriented, and tranquil

3. Awake but responds to commands only

4. Asleep; brisk response to light glabellar tap or loud auditory stimulus

5. Asleep; sluggish response to light glabellar tap or loud auditory stimulus

6. Asleep; no response to glabellar tap or loud auditory stimulus

Intra operative heart ratewithin 24 hours postoperative

beats per minutes

Visual Analogue Scale1, 2, 4, 6, 8, 12 and 24 hours postoperative

VAS score at rest and during movement and cough The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be')

Onset of motor block using Bromage scalePost spinal anesthesia up to 30 minutes

defined as the time from giving spinal anesthesia until a modified Bromage score of IV will be reached),Duration of motor block (defined as the time from spinal anesthesia until Modified Bromage score of I).

Nausea and vomitingintraoperative and postoperative 24 hours

Nausea and vomiting

Trial Locations

Locations (1)

Faculty of Medicine, Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath